Oxaliplatin-induced lung fibrosis

Oxaliplatin has been approved for use as an adjuvant treatment in stage III colorectal carcinoma by the US-FDA. The majority of toxicity caused by this drug is manageable. However, rare, isolated cases of pulmonary fibrosis induced by this drug have been reported in literature. We report one such ca...

Descripción completa

Detalles Bibliográficos
Autores principales: Shah, Arpan, Udwadia, Zarir F., Almel, Sachin
Formato: Texto
Lenguaje:English
Publicado: Medknow Publications 2009
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2930291/
https://www.ncbi.nlm.nih.gov/pubmed/20838550
http://dx.doi.org/10.4103/0971-5851.64259
_version_ 1782185980214640640
author Shah, Arpan
Udwadia, Zarir F.
Almel, Sachin
author_facet Shah, Arpan
Udwadia, Zarir F.
Almel, Sachin
author_sort Shah, Arpan
collection PubMed
description Oxaliplatin has been approved for use as an adjuvant treatment in stage III colorectal carcinoma by the US-FDA. The majority of toxicity caused by this drug is manageable. However, rare, isolated cases of pulmonary fibrosis induced by this drug have been reported in literature. We report one such case of rapidly evolving pulmonary fibrosis following treatment with oxaliplatin.
format Text
id pubmed-2930291
institution National Center for Biotechnology Information
language English
publishDate 2009
publisher Medknow Publications
record_format MEDLINE/PubMed
spelling pubmed-29302912010-09-13 Oxaliplatin-induced lung fibrosis Shah, Arpan Udwadia, Zarir F. Almel, Sachin Indian J Med Paediatr Oncol Case Report Oxaliplatin has been approved for use as an adjuvant treatment in stage III colorectal carcinoma by the US-FDA. The majority of toxicity caused by this drug is manageable. However, rare, isolated cases of pulmonary fibrosis induced by this drug have been reported in literature. We report one such case of rapidly evolving pulmonary fibrosis following treatment with oxaliplatin. Medknow Publications 2009 /pmc/articles/PMC2930291/ /pubmed/20838550 http://dx.doi.org/10.4103/0971-5851.64259 Text en © Indian Journal of Medical and Paediatric Oncology http://creativecommons.org/licenses/by/2.0 This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Report
Shah, Arpan
Udwadia, Zarir F.
Almel, Sachin
Oxaliplatin-induced lung fibrosis
title Oxaliplatin-induced lung fibrosis
title_full Oxaliplatin-induced lung fibrosis
title_fullStr Oxaliplatin-induced lung fibrosis
title_full_unstemmed Oxaliplatin-induced lung fibrosis
title_short Oxaliplatin-induced lung fibrosis
title_sort oxaliplatin-induced lung fibrosis
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2930291/
https://www.ncbi.nlm.nih.gov/pubmed/20838550
http://dx.doi.org/10.4103/0971-5851.64259
work_keys_str_mv AT shaharpan oxaliplatininducedlungfibrosis
AT udwadiazarirf oxaliplatininducedlungfibrosis
AT almelsachin oxaliplatininducedlungfibrosis

Ejemplares similares